Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.

Emery MG, Fisher JM, Chien JY, Kharasch ED, Dellinger EP, Kowdley KV, Thummel KE.

Hepatology. 2003 Aug;38(2):428-35.

PMID:
12883487
2.

Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.

Chtioui H, Semela D, Ledermann M, Zimmermann A, Dufour JF.

Liver Int. 2007 Aug;27(6):764-71.

PMID:
17617119
3.

Changes in microsomal activity in alcoholism and obesity.

de la Maza MP, Hirsch S, Petermann M, Suazo M, Ugarte G, Bunout D.

Alcohol Clin Exp Res. 2000 May;24(5):605-10.

PMID:
10832901
4.

Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women.

Varela NM, Quiñones LA, Orellana M, Poniachik J, Csendes A, Smok G, Rodrigo R, Cáceres DD, Videla LA.

Biol Res. 2008;41(1):81-92. doi: /S0716-97602008000100010. Epub 2008 Aug 21.

5.

Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery.

Mottin CC, Moretto M, Padoin AV, Kupski C, Swarowsky AM, Glock L, Duval V, da Silva JB.

Obes Surg. 2005 Jun-Jul;15(6):788-93.

PMID:
15978148
6.

Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.

Liew PL, Lee WJ, Wang W, Lee YC, Chen WY, Fang CL, Huang MT.

Obes Surg. 2008 Jul;18(7):847-53. doi: 10.1007/s11695-007-9355-0. Epub 2008 May 6.

PMID:
18459024
7.

Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters.

Wolf AM, Busch B, Kuhlmann HW, Beisiegel U.

Obes Surg. 2005 Feb;15(2):228-37.

PMID:
15802066
8.

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.

Obes Surg. 2006 Dec;16(12):1584-93.

PMID:
17217634
9.

Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity.

Stratopoulos C, Papakonstantinou A, Terzis I, Spiliadi C, Dimitriades G, Komesidou V, Kitsanta P, Argyrakos T, Hadjiyannakis E.

Obes Surg. 2005 Sep;15(8):1154-60.

PMID:
16197789
10.

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.

Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C.

Hepatology. 1998 Jan;27(1):128-33.

PMID:
9425928
11.

Regression of hepatic steatosis in morbidly obese persons after gastric bypass.

Silverman EM, Sapala JA, Appelman HD.

Am J Clin Pathol. 1995 Jul;104(1):23-31.

PMID:
7611176
12.
13.

Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease.

Prompila N, Wittayalertpanya S, Komolmit P.

J Med Assoc Thai. 2008 May;91(5):733-8.

PMID:
18672640
14.

Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.

Abrams GA, Kunde SS, Lazenby AJ, Clements RH.

Hepatology. 2004 Aug;40(2):475-83.

PMID:
15368453
15.

High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

Sabaté JM, Jouët P, Harnois F, Mechler C, Msika S, Grossin M, Coffin B.

Obes Surg. 2008 Apr;18(4):371-7. doi: 10.1007/s11695-007-9398-2. Epub 2008 Feb 20.

PMID:
18286348
16.

Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.

Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA.

Clin Gastroenterol Hepatol. 2007 Nov;5(11):1329-32. Epub 2007 Aug 16.

PMID:
17702661
17.

Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.

O'Shea D, Davis SN, Kim RB, Wilkinson GR.

Clin Pharmacol Ther. 1994 Oct;56(4):359-67.

PMID:
7955797
18.

Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation.

Lucas D, Farez C, Bardou LG, Vaisse J, Attali JR, Valensi P.

Fundam Clin Pharmacol. 1998;12(5):553-8.

PMID:
9794154
19.

Nonalcoholic fatty liver disease treated by gastroplasty.

Jaskiewicz K, Raczynska S, Rzepko R, Sledziński Z.

Dig Dis Sci. 2006 Jan;51(1):21-6.

PMID:
16416204
20.

CYP2E1 expression in human lymphocytes from various ethnic populations.

Raucy JL, Schultz ED, Kearins MC, Arora S, Johnston DE, Omdahl JL, Eckmann L, Carpenter SP.

Alcohol Clin Exp Res. 1999 Dec;23(12):1868-74.

PMID:
10630604

Supplemental Content

Support Center